|
Platsoucas, Chris D; Fincke, John E; Pappas, John et al. (2003) Immune responses to human tumors: development of tumor vaccines. Anticancer Res 23:1969-96
|
|
Melichar, B; Nash, M A; Lenzi, R et al. (2000) Expression of costimulatory molecules CD80 and CD86 and their receptors CD28, CTLA-4 on malignant ascites CD3+ tumour-infiltrating lymphocytes (TIL) from patients with ovarian and other types of peritoneal carcinomatosis. Clin Exp Immunol 119:19-27
|
|
Freedman, R S; Kudelka, A P; Kavanagh, J J et al. (2000) Clinical and biological effects of intraperitoneal injections of recombinant interferon-gamma and recombinant interleukin 2 with or without tumor-infiltrating lymphocytes in patients with ovarian or peritoneal carcinoma. Clin Cancer Res 6:2268-78
|
|
Loercher, A E; Nash, M A; Kavanagh, J J et al. (1999) Identification of an IL-10-producing HLA-DR-negative monocyte subset in the malignant ascites of patients with ovarian carcinoma that inhibits cytokine protein expression and proliferation of autologous T cells. J Immunol 163:6251-60
|
|
Gordinier, M E; Zhang, H Z; Patenia, R et al. (1999) Quantitative analysis of transforming growth factor beta 1 and 2 in ovarian carcinoma. Clin Cancer Res 5:2498-505
|
|
Freedman, R S; Lenzi, R; Kudelka, A P et al. (1998) Intraperitoneal immunotherapy of peritoneal carcinomatosis. Cytokines Cell Mol Ther 4:121-40
|
|
Nash, M A; Lenzi, R; Edwards, C L et al. (1998) Differential expression of cytokine transcripts in human epithelial ovarian carcinoma by solid tumour specimens, peritoneal exudate cells containing tumour, tumour-infiltrating lymphocyte (TIL)-derived T cell lines and established tumour cell lines. Clin Exp Immunol 112:172-80
|
|
Melichar, B; Savary, C; Kudelka, A P et al. (1998) Lineage-negative human leukocyte antigen-DR+ cells with the phenotype of undifferentiated dendritic cells in patients with carcinoma of the abdomen and pelvis. Clin Cancer Res 4:799-809
|
|
Melichar, B; Ferrandina, G; Verschraegen, C F et al. (1998) Growth inhibitory effects of aromatic fatty acids on ovarian tumor cell lines. Clin Cancer Res 4:3069-76
|
|
Ferrandina, G; Melichar, B; Loercher, A et al. (1997) Growth inhibitory effects of sodium phenylacetate (NSC 3039) on ovarian carcinoma cells in vitro. Cancer Res 57:4309-15
|
Showing the most recent 10 out of 13 publications
